109 related articles for article (PubMed ID: 21084279)
21. Characterization of centrosomal association of nucleophosmin/B23 linked to Crm1 activity.
Shinmura K; Tarapore P; Tokuyama Y; George KR; Fukasawa K
FEBS Lett; 2005 Dec; 579(29):6621-34. PubMed ID: 16297385
[TBL] [Abstract][Full Text] [Related]
22. BRCA2 localization to the midbody by filamin A regulates cep55 signaling and completion of cytokinesis.
Mondal G; Rowley M; Guidugli L; Wu J; Pankratz VS; Couch FJ
Dev Cell; 2012 Jul; 23(1):137-52. PubMed ID: 22771033
[TBL] [Abstract][Full Text] [Related]
23. BRCA2 phosphorylated by PLK1 moves to the midbody to regulate cytokinesis mediated by nonmuscle myosin IIC.
Takaoka M; Saito H; Takenaka K; Miki Y; Nakanishi A
Cancer Res; 2014 Mar; 74(5):1518-28. PubMed ID: 24448238
[TBL] [Abstract][Full Text] [Related]
24. PCNA and JNK1-Stat3 pathways respectively promotes and inhibits diabetes-associated centrosome amplification by targeting at the ROCK1/14-3-3σ complex in human colon cancer HCT116 cells.
Lu YC; Wang P; Wang J; Ma R; Lee SC
J Cell Physiol; 2019 Jul; 234(7):11511-11523. PubMed ID: 30478982
[TBL] [Abstract][Full Text] [Related]
25. Lats1 suppresses centrosome overduplication by modulating the stability of Cdc25B.
Mukai S; Yabuta N; Yoshida K; Okamoto A; Miura D; Furuta Y; Abe T; Nojima H
Sci Rep; 2015 Nov; 5():16173. PubMed ID: 26530630
[TBL] [Abstract][Full Text] [Related]
26. Germ-line mutations in BRCA1 or BRCA2 in the normal breast are associated with altered expression of estrogen-responsive proteins and the predominance of progesterone receptor A.
Mote PA; Leary JA; Avery KA; Sandelin K; Chenevix-Trench G; Kirk JA; Clarke CL;
Genes Chromosomes Cancer; 2004 Mar; 39(3):236-48. PubMed ID: 14732925
[TBL] [Abstract][Full Text] [Related]
27. Absence of Brca2 causes genome instability by chromosome breakage and loss associated with centrosome amplification.
Tutt A; Gabriel A; Bertwistle D; Connor F; Paterson H; Peacock J; Ross G; Ashworth A
Curr Biol; 1999 Oct; 9(19):1107-10. PubMed ID: 10531007
[TBL] [Abstract][Full Text] [Related]
28. Evidence that the tumor-suppressor protein BRCA2 does not regulate cytokinesis in human cells.
Lekomtsev S; Guizetti J; Pozniakovsky A; Gerlich DW; Petronczki M
J Cell Sci; 2010 May; 123(Pt 9):1395-400. PubMed ID: 20356927
[TBL] [Abstract][Full Text] [Related]
29. Novel BRCA2-Interacting Protein, LIMD1, Is Essential for the Centrosome Localization of BRCA2 in Esophageal Cancer Cell.
Hou X; Li T; Ren Z; Liu Y
Oncol Res; 2016; 24(4):247-53. PubMed ID: 27656835
[TBL] [Abstract][Full Text] [Related]
30. BRCA2 germline mutations in Cypriot patients with familial breast/ovarian cancer.
Hadjisavvas A; Charalambous E; Adamou A; Christodoulou CG; Kyriacou K
Hum Mutat; 2003 Feb; 21(2):171. PubMed ID: 12552570
[TBL] [Abstract][Full Text] [Related]
31. BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy.
Ottini L; Masala G; D'Amico C; Mancini B; Saieva C; Aceto G; Gestri D; Vezzosi V; Falchetti M; De Marco M; Paglierani M; Cama A; Bianchi S; Mariani-Costantini R; Palli D
Cancer Res; 2003 Jan; 63(2):342-7. PubMed ID: 12543786
[TBL] [Abstract][Full Text] [Related]
32. Morgana/chp-1, a ROCK inhibitor involved in centrosome duplication and tumorigenesis.
Ferretti R; Palumbo V; Di Savino A; Velasco S; Sbroggiò M; Sportoletti P; Micale L; Turco E; Silengo L; Palumbo G; Hirsch E; Teruya-Feldstein J; Bonaccorsi S; Pandolfi PP; Gatti M; Tarone G; Brancaccio M
Dev Cell; 2010 Mar; 18(3):486-95. PubMed ID: 20230755
[TBL] [Abstract][Full Text] [Related]
33. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.
Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG
Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460
[TBL] [Abstract][Full Text] [Related]
34. A comprehensive analysis of BRCA2 gene: focus on mechanistic aspects of its functions, spectrum of deleterious mutations, and therapeutic strategies targeting BRCA2-deficient tumors.
Shailani A; Kaur RP; Munshi A
Med Oncol; 2018 Jan; 35(3):18. PubMed ID: 29387975
[TBL] [Abstract][Full Text] [Related]
35. An IKKα-nucleophosmin axis utilizes inflammatory signaling to promote genome integrity.
Xia X; Liu S; Xiao Z; Zhu F; Song NY; Zhou M; Liu B; Shen J; Nagashima K; Veenstra TD; Burkett S; Datla M; Willette-Brown J; Shen H; Hu Y
Cell Rep; 2013 Dec; 5(5):1243-55. PubMed ID: 24290756
[TBL] [Abstract][Full Text] [Related]
36. Nucleophosmin is required for chromosome congression, proper mitotic spindle formation, and kinetochore-microtubule attachment in HeLa cells.
Amin MA; Matsunaga S; Uchiyama S; Fukui K
FEBS Lett; 2008 Nov; 582(27):3839-44. PubMed ID: 18951898
[TBL] [Abstract][Full Text] [Related]
37. Germline mutations in the BRCA1 and BRCA2 genes in Turkish breast/ovarian cancer patients.
Manguoglu AE; Lüleci G; Ozçelik T; Colak T; Schayek H; Akaydin M; Friedman E
Hum Mutat; 2003 Apr; 21(4):444-5. PubMed ID: 12655560
[TBL] [Abstract][Full Text] [Related]
38. Chinese hamster cell mutant, V-C8, a model for analysis of Brca2 function.
Wiegant WW; Overmeer RM; Godthelp BC; van Buul PP; Zdzienicka MZ
Mutat Res; 2006 Aug; 600(1-2):79-88. PubMed ID: 16643964
[TBL] [Abstract][Full Text] [Related]
39. Roles of BCCIP in chromosome stability and cytokinesis.
Meng X; Fan J; Shen Z
Oncogene; 2007 Sep; 26(43):6253-60. PubMed ID: 17452982
[TBL] [Abstract][Full Text] [Related]
40. BubR1 localizes to centrosomes and suppresses centrosome amplification via regulating Plk1 activity in interphase cells.
Izumi H; Matsumoto Y; Ikeuchi T; Saya H; Kajii T; Matsuura S
Oncogene; 2009 Aug; 28(31):2806-20. PubMed ID: 19503101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
